[CLSTR]
< Back to situations

[ORGANIZATION]

Heart Failure Society of America

Featured in 8 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [EC] [VN]

Rising cardiovascular disease in young adults

7 clusters · 24 sources · last updated

Latest: Global Burden of Disease study highlights rising heart failure trends

Recent medical data indicates a significant rise in cardiovascular issues among younger populations. A study in the journal Neurology found that stroke rates for adults aged 20 to 54 nearly doubled between 1993 and 2020,

[ACTIVE] [HEALTH] [US] [GB] [SE]

Expanding therapeutic uses and regulatory approvals for GLP-

32 clusters · 152 sources · last updated

Latest: Semaglutide benefits extend beyond weight loss to heart and kidney health

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

[QUIET] [HEALTH]

HFSA 2026 heart failure clinical trial data

2 clusters · 3 sources · last updated

Latest: Tovinontrine 50 mg improves cGMP but shows minimal NT-proBNP effect in HFpEF trial

At the Heart Failure Society of America (HFSA) 2026 annual meeting, clinical data were presented for several heart failure treatments. Cardurion Pharmaceuticals reported Phase 2 results for the PDE9 inhibitor tovinontri

Also covered in